Nalagenetics: Funding, Investors & Team (Oct 2026)
Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatal reactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic.
Nalagenetics has raised $12.6M across 1 funding round on record, the most recent a Series A of $12.6M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nalagenetics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Nalagenetics Funding Rounds
Nalagenetics Founders and Leadership Team
Contact details for the Nalagenetics team: 1 of 1 has an email address on file.
Start 14-day free trial →Nalagenetics Funding Compared to Other Biotechnology Startups
Nalagenetics' latest round of $12.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nalagenetics in Biotechnology and Singapore
Companies Similar to Nalagenetics
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Nalagenetics Funding FAQs
What does Nalagenetics do?
Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatal reactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic.
How much funding has Nalagenetics raised?
Nalagenetics has raised $12.6M across 1 round on record. The most recent is a Series A of $12.6M announced in Mar 2022.
When did Nalagenetics last raise funding?
Nalagenetics' most recent funding round on record is a Series A of $12.6M, announced in Mar 2022.
Who founded Nalagenetics?
FundedIQ lists Levana Sani (Founder) at Nalagenetics.
Where is Nalagenetics headquartered?
Nalagenetics is based in Singapore, Central Region, Singapore.
How many employees does Nalagenetics have?
Nalagenetics is in the 51-100 employee band.
How does Nalagenetics' funding compare to other Biotechnology startups?
Nalagenetics' latest round of $12.6M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Nalagenetics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nalagenetics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.